Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Human papillomavirus vaccine recombinant quadrivalent

Venous thromboembolism (?) and anaphylaxis: 6 case reports

    • 13 Accesses

    This is a preview of subscription content, log in to check access.

    REFERENCE

    1. 1.

      Gee J, Naleway A, Shui I, Baggs J, Yin R, Li R, Kulldorff M, LEWIS E, Fireman B, Daley MF, Klein NP, Weintraub ES.Monitoring the safety of quadrivalent human papillomavirus vaccine: Findings from the Vaccine Safety Datalink. Vaccine 29: 8279-8284, No. 46, 26 Oct 2011. Available from: URL: http://dx.doi.org/10.1016/j.vaccine.2011.08.106 - USA

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Human papillomavirus vaccine recombinant quadrivalent. React. Wkly. 1396, 24 (2012). https://doi.org/10.2165/00128415-201213960-00085

    Download citation

    Keywords

    • Public Health
    • Spinal Cord
    • Cohort Study
    • Patient Outcome
    • Spinal Cord Injury